US Bancorp
ABCL icon

US Bancorp’s AbCellera Biologics ABCL Stock Holding History

US Bancorp’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8K Hold
611
– – ﹤0.01% 3669
2026
Q1 		$2.13K Hold
611
– – ﹤0.01% 3789
2025
Q4 		$2.09K Sell
611
-864
-59% -$3.86K ﹤0.01% 3749
2025
Q3 		$7.42K Buy
1,475
+87
+6% +$383 ﹤0.01% 3411
2025
Q2 		$4.76K Sell
1,388
-1,616
-54% -$4.02K ﹤0.01% 3654
2025
Q1 		$6.7K Buy
3,004
+1,048
+54% +$3.01K ﹤0.01% 3568
2024
Q4 		$5.73K Buy
1,956
+460
+31% +$1.28K ﹤0.01% 3609
2024
Q3 		$3.89K Sell
1,496
-100
-6% -$277 ﹤0.01% 3651
2024
Q2 		$4.72K Sell
1,596
-1,359
-46% -$5.14K ﹤0.01% 3531
2024
Q1 		$13.4K Hold
2,955
– – ﹤0.01% 3233
2023
Q4 		$16.9K Buy
2,955
+721
+32% +$3.34K ﹤0.01% 3128
2023
Q3 		$10.3K Buy
2,234
+18
+0.8% +$110 ﹤0.01% 3166
2023
Q2 		$14.3K Buy
2,216
+1,060
+92% +$7.23K ﹤0.01% 3128
2023
Q1 		$8.72K Sell
1,156
-274
-19% -$2.49K ﹤0.01% 3334
2022
Q4 		$14.5K Buy
1,430
+1,360
+1,943% +$15.7K ﹤0.01% 3165
2022
Q3 		$1K Buy
+70
New +$768 ﹤0.01% 3902
2021
Q3 		– Sell
-500
Closed -$11K – 4056
2021
Q2 		$11K Buy
500
+416
+495% +$11.5K ﹤0.01% 3356
2021
Q1 		$3K Buy
+84
New +$3.35K ﹤0.01% 3586

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

US Bancorp's ABCL Position: Q2 2026 in Review

US Bancorp held its AbCellera Biologics (ABCL) position steady in Q2 2026 at 611 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3669.

US Bancorp first reported a position in ABCL in Q1 2021 and has held it in 18 quarters since. The position peaked at $16.9K in Q4 2023. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • US Bancorp held 611 shares of AbCellera Biologics worth $4.8K as of Q2 2026.
  • US Bancorp left its AbCellera Biologics share count unchanged in Q2 2026.
  • AbCellera Biologics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3669 holding.
  • US Bancorp first reported a position in AbCellera Biologics in Q1 2021 and has held it in 18 quarters since.
  • US Bancorp's AbCellera Biologics position peaked at $16.9K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.